AICARDI-GOUTIERES SYNDROME
|
0.700 |
Biomarker
|
disease |
BEFREE |
Among these, IFIH1 encodes for MDA5, a cytosolic double-stranded RNA receptor, and is responsible for AGS type 7.
|
31698194 |
2019 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Using a newly developed RNase-protection/RNA-seq approach, we demonstrate here that constitutive activation of MDA5 in AGS results from the loss of tolerance to cellular dsRNAs formed by Alu retroelements.
|
29395326 |
2018 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
All studied individuals with AGS were noted to have elevated IFN signature scores (Mann-Whitney p < .001), with the highest levels in individuals with IFIH1 mutations (Mann-Whitney p < .0001).
|
30219631 |
2018 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Interferon signature was elevated in one subject who presented also a mutation of the IFIH1 gene.AGS should be considered in sine-causa tetraparesis.
|
30593198 |
2018 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Within recent years, with the help of next generation sequencing techniques in syndromic families, mutations in the genes encoding for RIG-I and MDA5 have been identified to cause rare diseases including Aicardi-Goutières syndrome, Systemic Lupus Erythematosus in certain individuals as well as classic and atypical Singleton-Merten syndrome.
|
26993858 |
2016 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A de novo pathogenic variant in the IFIH1 gene which has recently been shown to cause autosomal dominant forms of Aicardi-Goutières syndrome was identified.
|
26833990 |
2016 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
Biomarker
|
disease |
BEFREE |
Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.
|
27643693 |
2016 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.
|
25604658 |
2015 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Our results further extend the phenotypic spectrum associated with mutations in IFIH1, indicating that the disease can be confined predominantly to the skin, while also highlighting phenotypic overlap with both Aicardi-Goutières syndrome and Singleton-Merten syndrome.
|
26284909 |
2015 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
Biomarker
|
disease |
BEFREE |
IFIH1 has been linked to a number of autoimmune disorders, including Aicardi-Goutières syndrome.
|
25620204 |
2015 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The same mutation in IFIH1 was recently identified in patients with Aicardi-Goutières syndrome, a rare neuroimmunologic disorder associated with elevated levels of type I interferon (IFN).
|
25777993 |
2015 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This study suggests that the IFIH1 mutations are responsible for the AGS phenotype due to an excessive production of type I interferon.
|
24995871 |
2014 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.
|
24686847 |
2014 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
Biomarker
|
disease |
CTD_human |
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.
|
24686847 |
2014 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant IFIH1 gain-of-function mutations cause Aicardi-Goutières syndrome.
|
25080300 |
2014 |
AICARDI-GOUTIERES SYNDROME
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
This study suggests that the IFIH1 mutations are responsible for the AGS phenotype due to an excessive production of type I interferon.
|
24995871 |
2014 |